29/10/2020 5:39 am Welcome to isteroids.com - BLOG

Wednesday 07, Jul 2010

  Potential treatment for hay fever and asthma identified

Posted By
Pin it Share on Tumblr

Potential treatment for hay fever and asthma identifiedA potential drug has been identified and about to undergo trials in humans for treating hay fever and asthma.

The drug, RPL554, apparently has the ability to effectively treat respiratory diseases and does not lead to side effects that are usually common characteristics of many of the currently used medications.

It was remarked by Dr. Clive Page, chairman of Verona Pharma, which is developing the treatment, that his company is also ascertaining other novel compounds to tackle respiratory diseases on the lines of anti-inflammatory substances found in starfish and a treatment for coughs.

Thursday 13, May 2010

  Once a day treatment with RPL554 for asthma and hay fever patients

Posted By
Pin it Share on Tumblr

Once a day treatment with RPL554 for asthma and hay fever patientsA new drug, RPL554, was recently found to be effective in treating asthma and hay fever and is about to undergo trials in humans.

The drug, apparently, has the capability of effectively treating respiratory diseases and is without side effects that are regular features with many of the presently available drugs.

Dr. Clive Page, chairman of Verona Pharma, which is developing the treatment, said that the company is also evaluating other novel compounds for tackling respiratory diseases based on anti-inflammatory substances found in starfish and a treatment for coughs.

Sunday 14, Mar 2010

  Hay fever and asthmatic patients can expect miracle relief

Posted By
Pin it Share on Tumblr

Hay fever and asthmatic patients can expect miracle reliefHay fever and asthma patients can expect a good surprise in the times to come if a new drug, RPL554, is able to live up to expectations of effectively treating respiratory diseases but without many of the side-effects most presently-available drugs produce.

The trial to check efficacy of RPL554 started in November 2009 and is expected to be completed by this summer.

According to Dr. Clive Page, chairman of Verona Pharma and a professor of pharmacology at King’s College London, RPL554 is the sole molecule expected to have a low side effect profile. Once-a-day treatment with it can provide significant relief to asthma and hay fever patients.

Thursday 04, Feb 2010

  Trials in line for potential asthma drug

Posted By
Pin it Share on Tumblr

Trials in line for potential asthma drugRPL554, a potential drug for providing relief to patients suffering from asthma is undergoing human trials in the near future after it successfully cleared trials on more than 60 people in the year 2008 at the Centre for Human Drug Research (CHDR) in the Netherlands.

The drug is believed to offer a crucial insight to medical practitioners across the globe to treat asthmatic patients. This potential drug for asthma is expected to reach the market in the next 3-5 years after successful completion of initial trials for safety and efficacy.

Some practitioners are of the view that this drug will help them to draw new and improved treatment plans for treating their asthmatic patients.

Wednesday 18, Nov 2009

  New Asthma Drug heading for Human Trials

Posted By
Pin it Share on Tumblr

New Asthma Drug heading for Human TrialsRPL554, a new drug for treating asthma, that faced trial at the Centre for Human Drug Research (CHDR) in the Netherlands on more than 60 people in 2008, is now expected to head for human trials during 2009.

The drug, which is hailed by some as nothing short of a miracle drug, may prove beneficial to 1.5 million people in the United States alone suffering from asthma and hay fever. This drug is expected to be available in the market in the coming three to four years pending to the success of initial trials for efficacy and safety.

Some researchers are of the view that this once-a-day asthma treatment option would act as a potential first-line therapy for curing patients suffering from asthma and hay fever. This will also mean that patients with asthma would now require only a single needle puff from their “lifesaving” inhalers to stop the symptoms.

Wednesday 14, Oct 2009

  New drug for asthma treatment heads for human trials

Posted By
Pin it Share on Tumblr

New drug for asthma treatment heads for human trialsA new drug, RPL554, which faced trial at the Centre for Human Drug Research (CHDR) in the Netherlands on as many as 60 people in 2008, is expected to be completed by the summer of 2009.

This drug is aimed at treating asthma, which affects more than 1.5 million people in the United States alone, and hay fever. It is believed that the drug could be made available in approximately three to four years if the initial trials for safety and efficacy are found to be successful.

 

It is considered by many researchers that this once-a-day treatment option will be regarded as a potential breakthrough when it comes to treating asthma and hay fever. The treatment option would bring relief to asthma sufferers and its use would mean that asthmatic people would be requiring only a single needle puff from their “lifesaving” inhalers to stop the symptoms.